๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Adult Cancer Patients

IMA402 T Cell-Engaging Receptor Molecule (TCERยฎ) in Recurrent and/or Refractory Solid Tumors NCT05958121Phase 1, Phase 229 sites๐Ÿ“ Heidelberg๐Ÿ“ Heidelberg๐Ÿ“ Mannheim Immatics Biotechnologies GmbH ยท Tests: IMA402, IMA402 and checkpoint inhibitor, IMA402 and chemotherapy, IMA402 and IMA401, IMA402 and monoclonal antibody Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) NCT04427384n/a54 sites๐Ÿ“ Phoenix๐Ÿ“ Little Rock๐Ÿ“ Castro Valley GT Medical Technologies, Inc. ยท Tests: GammaTile Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site๐Ÿ“ Durham Duke University Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor NCT07570485NA1 site๐Ÿ“ Rennes Center Eugene Marquis ยท Tests: adapted physical activity A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors NCT05866692Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Jinan TYK Medicines, Inc ยท Tests: TY-2699a Whole Genome Sequencing (ChromoSeqยฎ) for Acute Lymphoblastic Leukemia (ALL) Patients NCT07313592n/a1 site๐Ÿ“ St Louis Washington University School of Medicine Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340Phase 1, Phase 254 sites๐Ÿ“ Birmingham๐Ÿ“ Boston๐Ÿ“ Boston Regeneron Pharmaceuticals ยท Tests: Ubamatamab, Cemiplimab, Sarilumab, Tocilizumab A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682Phase 1, Phase 21 site๐Ÿ“ Tianjin Jacobio Pharmaceuticals Co., Ltd. ยท Tests: JAB-8263, JAB-8263 Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma NCT05798897Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ Aurora๐Ÿ“ Denver Marker Therapeutics, Inc. ยท Tests: MT-601 A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement NCT07359820Phase 219 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Tampa Elevar Therapeutics ยท Tests: Lirafugratinib A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma NCT07075328Phase 1, Phase 25 sites๐Ÿ“ Fukuoka๐Ÿ“ Sapporo๐Ÿ“ Kagoshima Otsuka Medical Devices Co., Ltd. Japan ยท Tests: Drug:5-ALA, Device:Photodynamic system A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer NCT06609005Phase 1, Phase 222 sites๐Ÿ“ Scottsdale๐Ÿ“ Newport Beach๐Ÿ“ Orange Shenzhen Ionova Life Sciences Co., Ltd. ยท Tests: INV-9956 A Pilot Randomized Controlled Trial of a Social Network Intervention NCT07393529NA1 site๐Ÿ“ Rochester University of Rochester ยท Tests: SONATA CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia NCT07361029Phase 11 site๐Ÿ“ Riyadh King Faisal Specialist Hospital & Research Center ยท Tests: CAR T cells chimeric antigen receptor cells Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors NCT05372640Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Cancer Institute (NCI) ยท Tests: Abemaciclib, BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. NCT05939414Phase 3144 sites๐Ÿ“ Fayetteville๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto Novartis Pharmaceuticals ยท Tests: AAA617, piflufolastat (18F), gallium (68Ga) gozetotide (25ฮผg) STRatifying Adult DIffuse Lower-grade Gliomas Based on Their VARIed Metabolic Profiles (STRADIVARI Project) NCT06794736n/a4 sites๐Ÿ“ Bari๐Ÿ“ Bari๐Ÿ“ Milan I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543NA3 sites๐Ÿ“ Washington D.C.๐Ÿ“ Baltimore๐Ÿ“ Minneapolis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Consolidative radiation therapy (cRT) Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy NCT05223608NA1 site๐Ÿ“ Lille Centre Oscar Lambret ยท Tests: ImmuCCo Cohort A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL) NCT06742996Phase 3145 sites๐Ÿ“ Birmingham๐Ÿ“ Tucson๐Ÿ“ Fresno BeOne Medicines ยท Tests: Sonrotoclax, Zanubrutinib, Placebo A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastinยฎ Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients NCT06496971Phase 32 sites๐Ÿ“ Taipei๐Ÿ“ Taoyuan NaviFUS Corporation ยท Tests: Bevacizumab, Microbubble, Low-Intensity Focused Ultrasound ORB-021 In Patients With Advanced Solid Tumors NCT06607939Phase 12 sites๐Ÿ“ Scottsdale๐Ÿ“ Houston Orionis Biosciences Inc ยท Tests: ORB-021 A Study of Questionnaires in Adolescents and Young Adults With Cancer NCT07212166n/a7 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Patient-Reported Outcome Surveys, Spanish version of PRO-AYA and the cognitive interview A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ Phoenix Center for International Blood and Marrow Transplant Researโ€ฆ ยท Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) A Telehealth Advance Care Planning Intervention NCT05875805NA1 site๐Ÿ“ Rochester University of Rochester ยท Tests: Telehealth Serious Illness Care Program, Education Control A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia NCT07400029Phase 29 sites๐Ÿ“ Duarte๐Ÿ“ Stanford๐Ÿ“ Basking Ridge Memorial Sloan Kettering Cancer Center ยท Tests: Obecabtagene Autoleucel DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers NCT05770037Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Alectinib A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors NCT06700070EARLY Phase 11 site๐Ÿ“ Shreveport Pure Biologics S.A. ยท Tests: PBA-0111 Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients NCT06311981Phase 21 site๐Ÿ“ Shanghai Jian Chen ยท Tests: carbon ion radiotherapy, targeted therapy, single regimen chemotherapy in sequence with radiotherapy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy